MDDiabeticPro
Discover, Control & Prevent diabetic risk.
How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.
Know your risk with DIABETESPredict™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
500 Million worldwide suffer
type-2 diabetes.
34.2 Million Americans, or 10.5% of the population, had diabetes.
Let’s Talk
We want to hear from you! Tell us more about your interest in MDChemistryPro today.
Read Our Blog
Utah Lab Acquisition Featured on Market Insider
https://bit.ly/37RDmXy
Heart Failure Awareness Week: Do You Know Your Risk?
About 6 million Americans are living with heart failure today, according to the Center for Disease Control and Prevention. Heart failure happens when the heart cannot pump enough blood and oxygen to support other organs in your body. Heart failure often develops after...
Heart Failure Awareness Week: COVID-19 Increases Risk for Heart Disease
If you’ve had even a mild case of COVID-19, you may have an increased risk of cardiovascular problems, according to a new study. From very early in the pandemic, doctors were vocal about SARS-CoV-2 being able to damage the heart and blood vessels. Since then, about...
Premier Medical Laboratory Services: Daniel Hughes – Featured on GenomeWeb
https://bit.ly/3Opyb1z
Premier Medical Laboratory Services Hires Bioinformatics Expert, Dr. Daniel Hughes
Dr. Daniel Hughes, M2Gen’s former Director of Cancer Knowledge Base and Pharma Services, has joined Premier Medical Laboratory Services (PMLS) as the Director of Bioinformatics. After spending more than 10 years in Bioinformatics, Dr. Hughes will be leading PMLS in...
New ‘Stealth’ Omicron BA.2 Variant Identified by Premier Medical Laboratory Services
When the Omicron variant first began to spread throughout the US, Premier Medical Laboratory Services (PMLS) identified one of the first cases in South Carolina through Next Generation Sequencing. Now, the laboratory is reporting their findings of one of the US’s...